---
title: "Lifecourse Mendelian randomization: childhood vs adulthood adiposity and later-life sleep outcomes"
id: "medrxiv-3-investigating-adiposity-in-childhood-and-adulthood-on-later-life-sleep-health-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-investigating-adiposity-in-childhood-and-adulthood-on-later-life-sleep-health-a"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Lifecourse Mendelian randomization: childhood vs adulthood adiposity and later-life sleep outcomes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-investigating-adiposity-in-childhood-and-adulthood-on-later-life-sleep-health-a
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This preprint used two-sample **Mendelian randomization** to test effects of genetically predicted **childhood adiposity** and **adulthood adiposity** on later-life sleep traits: insomnia, morning chronotype, sleep duration, daytime sleepiness and daytime napping. - Genetic instruments came from GWAS of UK Biobank body size (n=453,169) and large consortia for obstructive sleep apnea (OSA; Million Veteran Program, n=410,268), insomnia and chronotype (23andMe datasets; combined sample sizes reported in source). - Univariable MR found no evidence that genetically predicted childhood adiposity increased later-life **insomnia** risk (OR 0.94, 95% CI 0.87–1.03). - Multivariable MR adjusting for adulthood adiposity provided evidence of a direct *protective* effect of higher childhood body size on later-life insomnia (OR 0.70, 95% CI 0.64–0.77). - Both univariable and multivariable MR indicated a positive effect of increased childhood body size on being a **morning chronotype** (univariable OR 1.16, 95% CI 1.01–1.33; multivariable OR 1.36, 95% CI 1.15–1.62) after accounting for adulthood body size. - Adjusting additionally for **OSA** did not materially change those childhood adiposity estimates in the analyses reported. - Both childhood and adulthood adiposity were associated with **OSA**, and OSA was associated with insomnia in the reported analyses. - Increased adulthood body size increased risk of **insomnia** and of being a **morning chronotype** in both univariable and multivariable analyses. - Authors conclude that higher childhood adiposity is not a risk factor for later-life insomnia when adulthood adiposity is considered; if a healthy adult body size is maintained, higher childhood adiposity may reduce insomnia risk and increase likelihood of morningness in later life. - Data access statements and ethics approvals are reported: GWAS summary data available on request to UK Biobank, OSA data via MVP application, and insomnia/chronotype data from 23andMe on request. Competing interest: one author employed by GlaxoSmithKline; others report no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=nbkeC29M5XxI6ejU_BVo23.WCnYDwTVrFlfKJhIlrFw-1788216154.6732454-1.2.1.1-k5krJ7425zoXkg7EuhVMDcbDQ1YRTMa.6BAo7LPY5T0Hjh0gRraTNtDufhNQBtL3) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Investigating adiposity in childhood and adulthood on later life sleep health: a lifecourse Mendelian randomization study sweta pathak, Tom Richardson, Eleanor Sanderson, Nikhil Arora, Linn Strand, Bjorn Olav Asvold, Laxmi Bhatta, Ben Brumpton doi: https://doi.org/10.64898/2026.08.27.26361310 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. sweta pathak 1 Norwegian University of Science and Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=sweta%2Bpathak%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=pathak%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3Asweta%2Bpathak%2B) * For correspondence: sweta.b.pathak@gmail.com Tom Richardson 2 MRC Integrative Epidemiology Unit, University of Bristol; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tom%2BRichardson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Richardson%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATom%2BRichardson%2B) Eleanor Sanderson 3 University of Bristol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eleanor%2BSanderson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sanderson%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEleanor%2BSanderson%2B) Nikhil Arora 1 Norwegian University of Science and Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nikhil%2BArora%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Arora%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANikhil%2BArora%2B) Linn Strand 1 Norwegian University of Science and Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Linn%2BStrand%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Strand%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALinn%2BStrand%2B) Bjorn Olav Asvold 1 Norwegian University of Science and Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bjorn%2BOlav%2BAsvold%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Asvold%20BO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABjorn%2BOlav%2BAsvold%2B) Laxmi Bhatta 1 Norwegian University of Science and Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Laxmi%2BBhatta%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bhatta%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALaxmi%2BBhatta%2B) Ben Brumpton 1 Norwegian University of Science and Technology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ben%2BBrumpton%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Brumpton%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABen%2BBrumpton%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289282/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289282/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289282/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1289282/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289282/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289282/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Higher Body Mass Index (BMI) is an established risk factor of sleep disturbance. It is not known if the effect is homogeneous across the lifecourse or if there is a particular time point in life that might be best to target. Methods: Two-sample Mendelian randomization (MR) was used to investigated the effect of childhood adiposity (adjusting on adulthood adiposity and obstructive sleep apnea (OSA)) on insomnia, morning chronotype, sleep duration, daytime sleepiness and daytime napping. Similarly, total, and direct effect of adulthood adiposity on these outcomes was explored. We used summary statistics from a genome-wide association study (GWAS) of UK Biobank for childhood and adulthood adiposity (n=453,169) and large-scale consortia of OSA (Million Veteran Program) (n=410,268), insomnia, and chronotype (23andMe) (n=1,978,022 and n=248,1000, respectively). Results: Two-sample univariable MR analysis provided no evidence of an effect of genetically predicted childhood adiposity on later life insomnia (Odds ratio (OR)= 0.94, 95% Confidence interval (CI)= 0.87, 1.03). Whereas, multivariable MR (adjusted for adulthood adiposity) analysis provide strong evidence of direct protective effect of genetically predicted childhood adiposity on later life insomnia (OR= 0.70, CI= 0.64, 0.77). Further, both in univariable and multivariable MR, a strong positive effect of increased childhood body size on morning chronotype was observed (OR= 1.16, CI= 1.01, 1.33 and OR= 1.36, CI= 1.15, 1.62, respectively) after accounting for adulthood body size. In both analysis the estimate did not change considerably after aditionally adjusting for OSA. However, childhood and adulthood adiposity found to be associated with OSA and OSA with insomnia. In both univariable and multivariable analysis, increased body size in adulthood increased the risk of having insomnia and a morning chronotype. Conclusions: The findings suggest that higher body size in childhood is not a risk factor for later life insomnia, whereas higher body size in adulthood was. Further, if healthy body size is maintained in adulthood, high childhood adiposity may decrease the risk of insomnia and increase the risk of being a morning person in later life. Keywords: childhood, adulthood, obesity, insomnia, morning chronotype, medelian randomization ### Competing Interest Statement T.G.R. is a full time employee of GlaxoSmithKline outside of this research. The other authors declare that they have no competing interests. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: GWAS Summary statistic data of childhood and adulthood body size are available through request to UK Biobank. GWAS summary statistic of OSA can be accessed through application at: https://www.ncbi.nlm.nih.gov/gap/ under the MVP accession (phs001672). GWAS summary statistic of Insomnia and Chronotype are requested from 23andME. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability GWAS Summary statistic data of childhood and adulthood body size are available through request to UK Biobank. GWAS summary statistic of OSA can be accessed through application at: https://www.ncbi.nlm.nih.gov/gap/ under the MVP accession (phs001672). GWAS summary statistic of Insomnia and Chronotype are requested from 23andME. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.28.26361655v1 "A Multi-Agent Large Language Model Reasoning Engine for Early Detection of Pediatric Growth Disorders")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.26.26361479v1 "Acceptability, feasibility, quality of life and diabetes distress score outcomes: A pragmatic randomised clinical trial on continuous glucose monitoring for people with type 1 diabetes") Posted August 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/31/2026.08.27.26361310.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.27.26361310v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/31/2026.08.27.26361310.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Investigating adiposity in childhood and adulthood on later life sleep health: a lifecourse Mendelian randomization study sweta pathak, Tom Richardson, Eleanor Sanderson, Nikhil Arora, Linn Strand, Bjorn Olav Asvold, Laxmi Bhatta, Ben Brumpton medRxiv 2026.08.27.26361310; doi: https://doi.org/10.64898/2026.08.27.26361310 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361310v1%26text%3DInvestigating%2520adiposity%2520in%2520childhood%2520and%2520adulthood%2520on%2520later%2520life%2520sleep%2520health%253A%2520a%2520lifecourse%2520Mendelian%2520randomization%2520study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361310v1%26t%3DInvestigating%2520adiposity%2520in%2520childhood%2520and%2520adulthood%2520on%2520later%2520life%2520sleep%2520health%253A%2520a%2520lifecourse%2520Mendelian%2520randomization%2520study "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361310v1%26title%3DInvestigating%2520adiposity%2520in%2520childhood%2520and%2520adulthood%2520on%2520later%2520life%2520sleep%2520health%253A%2520a%2520lifecourse%2520Mendelian%2520randomization%2520study%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361310v1%26title%3DInvestigating%2520adiposity%2520in%2520childhood%2520and%2520adulthood%2520on%2520later%2520life%2520sleep%2520health%253A%2520a%2520lifecourse%2520Mendelian%2520randomization%2520study "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.27.26361310) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.27.26361310v1&count=horizontal&via=&text=Investigating%20adiposity%20in%20childhood%20and%20adulthood%20on%20later%20life%20sleep%20health%3A%20a%20lifecourse%20Mendelian%20randomization%20study&counturl=www.medrxiv.org/content/10.64898/2026.08.27.26361310v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (613) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (895) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (325) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4765) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (641) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1612) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15826) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6979) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1056) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4968) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1424) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1733) * [Hematology](https://www.medrxiv.org/collection/hematology) (579) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1333) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16239) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1160) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (720) * [Neurology](https://www.medrxiv.org/collection/neurology) (7186) * [Nursing](https://www.medrxiv.org/collection/nursing) (363) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1072) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1230) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (999) * [Oncology](https://www.medrxiv.org/collection/oncology) (3567) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1035) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (446) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (465) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1772) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (732) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https:
## Related Clinical Research

- [INSULIN Act: Bipartisan House Bill to Cap Insulin Cost and Improve Access](https://medichelpline.com/clinical-feed/endocrine-news-0-endocrine-society-applauds-introduction-of-bipartisan-bill-to-address-insulin.md)
- [Undiagnosed type 2 diabetes presenting as DKA with hypertriglyceridemia-induced acute pancreatitis](https://medichelpline.com/clinical-feed/cmaj-1-undiagnosed-type-2-diabetes-presenting-as-diabetic-ketoacidosis-with.md)
- [Insulet and Calm Partner to Offer Mindfulness Tools for People Living with Diabetes](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-july-17-2026.md)
- [COCCOS study protocol: evaluating a co-designed transition program for AYAs with chronic conditions](https://medichelpline.com/clinical-feed/pubmed-42607051.md) (DOI: 10.1371/journal.pone.0353932)
- [SNHG12 promotes diabetic nephropathy via the miR-129-5p / IL6ST regulatory axis](https://medichelpline.com/clinical-feed/pubmed-42579189.md) (DOI: 10.1007/s11033-026-12547-7)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.